[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72042]], camposKey:1120-6721 2022-07-01 Polymorphisms in CYP1B1 gene and the risk of suffering Primary Open-Angle Glaucoma: Systematic review and meta-analysis18411849, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46929]], camposKey:0030-3747 2019-01-01 Management and systemic implications of diabetic neovascular glaucoma111115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46930]], camposKey:1755-375X 2018-01-01 A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49615]], camposKey:0161-6420 2015-01-01 Association between SNPs of metalloproteinases and prostaglandin f2alpha receptor genes and latanoprost response in open-angle glaucoma10401048, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54080]], camposKey:0365-6691 2014-01-01 Ocular loiasis in a patient with chronic hypereosinophilia Loiasis ocular en paciente con hipereosinofilia crónica411413, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10819]], camposKey:0721-832X 2012-01-01 Can we measure mesopic pupil size with the cobalt blue light slit-lamp biomicroscopy method?16371647, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53661]], camposKey:0365-6691 2008-01-01 Decompression retinopathy with maculopathy after trabeculectomy with mitomycin C Retinopatía por descompresión con maculopatía tras trabeculectomía con mitomicina C373376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53285]], camposKey:0886-3350 2005-01-01 Flap tearing during lift-flap laser in situ keratomileusis retreatment20162018, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53288]], camposKey:1081-597X 2003-01-01 Subtarsal flap dislocation after superior hinge laser in situ keratomileusis in a patient with borderline mental illness169171, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53293]], camposKey:0161-6420 2002-01-01 Corneal flap thickness and tissue laser ablation in myopic LASIK [3]10421043, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53290]], camposKey:0886-3350 2002-01-01 Extensive corneal epithelial defect associated with internal hordeolum after uneventful laser in situ keratomileusis17001702, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44704]], camposKey:0365-6691 2002-01-01 Termoterapia transpupilar en neovascularización subretiniana oculta secundaria a degeneración macular asociada a la edad: Primeros resultados617621, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=83895]], camposKey:0365-6691 2002-01-01 Transpupillary thermotherapy in occult subretinal neovascularization in age-related macular degeneration. Preliminary results Termoterapia transpupilar en neovascularización subretiniana oculta secundaria a degeneración macular asociada a la edad. Primeros resultados.617622, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=734]], camposKey:0271-3683 1998-01-01 Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat3946, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42610]], camposKey:0365-6691 1997-01-01 Distribución de las uveítis en un centro de referencia665670, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=709]], camposKey:1081-1206 1996-01-01 Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy124130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=700]], camposKey:0927-3948 1996-01-01 Phlyctenular keratoconjunctivitis - A potentially blinding disorder119123, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=658]], camposKey:0146-0404 1995-01-01 OCULAR PENETRATION OF 1-PERCENT CYCLOSPORINE (CYA) FROM NANOCAPSULES AND CONVENTIONAL FORMATIONS IN RABBIT EYES00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40666]], camposKey:0146-0404 1995-01-01 TOPICAL APPLICATION OF NANOCAPSULES OF CYCLOSPORINE-A (CYA) ON A PENETRATING KERATOPLASTY REJECTION MODEL00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42620]], camposKey:0365-6691 1994-01-01 Factores clínicos que predisponen al fracaso de transplante de cornea: rechazo inmune659666][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19664]},camposKey: 21 23 Outcomes of combination treatments in refractory neovascular glaucoma. A retrospective review in patients with advanced proliferative diabetic retinopathy 978-88-7587-683-8The International Symposium on Ocular Pharmacology and Therapeutics: Proceedings of the 10th ISOPTClinical, Paris (France), March 7-10, 2013 1 2013-01-01 Monduzzi editore][][][][][][][][][][][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65218b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6512f9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651b7c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651cdf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651a70, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651a46, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651fc4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651fc1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@651537][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f375]][][CatedrasConvenios{id=22, codigoPersona=com.sigma.fs3.argos.domain.gpc.PersonalGPC[ifcidPers=23489], codigoTipo=CAT, codigoContable=null, titulo=CÁTEDRA ZEISS EN LA UNIVERSIDAD DE VALLADOLID, fechaInicio=2017-09-01, fechaFin=null, importe=12100.0, visiblePortal=1, visibleCvn=1, visibleMemoria=1, validado=S}][][][][][]